sorafenib has been researched along with Rhabdomyolysis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cervilla Sáez de Tejada, E; Díaz Alcázar, MDM; Ruiz Escolano, E | 1 |
2 other study(ies) available for sorafenib and Rhabdomyolysis
Article | Year |
---|---|
Rhabdomyolysis in a patient under treatment with sorafenib.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Prognosis; Rhabdomyolysis; Sorafenib | 2020 |
Sorafenib: muscle wasting.
Topics: Benzamides; Benzenesulfonates; Humans; Imatinib Mesylate; Indoles; Muscle, Skeletal; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Pyrroles; Rhabdomyolysis; Sorafenib; Sunitinib | 2011 |